505 related articles for article (PubMed ID: 26042634)
1. Efficacy and tolerability of treatments for bipolar depression.
Vázquez GH; Holtzman JN; Tondo L; Baldessarini RJ
J Affect Disord; 2015 Sep; 183():258-62. PubMed ID: 26042634
[TBL] [Abstract][Full Text] [Related]
2. Balancing benefits and harms of treatments for acute bipolar depression.
Ketter TA; Miller S; Dell'Osso B; Calabrese JR; Frye MA; Citrome L
J Affect Disord; 2014 Dec; 169 Suppl 1():S24-33. PubMed ID: 25533911
[TBL] [Abstract][Full Text] [Related]
3. Treatment of bipolar depression: making sensible decisions.
Citrome L
CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
[TBL] [Abstract][Full Text] [Related]
4. Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
Citrome L; Ketter TA; Cucchiaro J; Loebel A
J Affect Disord; 2014 Feb; 155():20-7. PubMed ID: 24246116
[TBL] [Abstract][Full Text] [Related]
5. Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics.
Selle V; Schalkwijk S; Vázquez GH; Baldessarini RJ
Pharmacopsychiatry; 2014 Mar; 47(2):43-52. PubMed ID: 24549862
[TBL] [Abstract][Full Text] [Related]
6. Acceptability of Acute and Maintenance Pharmacotherapy of Bipolar Disorder: A Systematic Review of Randomized, Double-Blind, Placebo-Controlled Clinical Trials.
Bai Y; Yang H; Chen G; Gao K
J Clin Psychopharmacol; 2020; 40(2):167-179. PubMed ID: 32134852
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
Taylor DM; Cornelius V; Smith L; Young AH
Acta Psychiatr Scand; 2014 Dec; 130(6):452-69. PubMed ID: 25283309
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium.
Vázquez GH; Bahji A; Undurraga J; Tondo L; Baldessarini RJ
J Psychopharmacol; 2021 Aug; 35(8):890-900. PubMed ID: 34238049
[TBL] [Abstract][Full Text] [Related]
9. Second-Generation Antipsychotics in Management of Acute Pediatric Bipolar Depression: A Systematic Review and Meta-analysis.
Patel RS; Veluri N; Patel J; Patel R; Machado T; Diler R
J Child Adolesc Psychopharmacol; 2021 Oct; 31(8):521-530. PubMed ID: 34665020
[No Abstract] [Full Text] [Related]
10. Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis.
Kadakia A; Dembek C; Heller V; Singh R; Uyei J; Hagi K; Nosaka T; Loebel A
BMC Psychiatry; 2021 May; 21(1):249. PubMed ID: 33975574
[TBL] [Abstract][Full Text] [Related]
11. Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed?
Citrome L
Clin Schizophr Relat Psychoses; 2012 Jul; 6(2):76-85. PubMed ID: 22776634
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.
Cruz N; Sanchez-Moreno J; Torres F; Goikolea JM; Valentí M; Vieta E
Int J Neuropsychopharmacol; 2010 Feb; 13(1):5-14. PubMed ID: 19638254
[TBL] [Abstract][Full Text] [Related]
13. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
14. Olanzapine-fluoxetine combination for the treatment of bipolar depression.
Citrome L
Expert Opin Pharmacother; 2011 Dec; 12(17):2751-8. PubMed ID: 22035291
[TBL] [Abstract][Full Text] [Related]
15. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
16. An analysis of the efficacy of treatments for bipolar depression.
Nierenberg AA
J Clin Psychiatry; 2008; 69 Suppl 5():4-8. PubMed ID: 19265634
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of treatments for acute bipolar disorder: balancing therapeutic and adverse effects.
Srivastava S; Ketter TA
Clin Ther; 2011 Dec; 33(12):B40-8. PubMed ID: 22177379
[TBL] [Abstract][Full Text] [Related]
18. Important clinical features of atypical antipsychotics in acute bipolar depression that inform routine clinical care: a review of pivotal studies with number needed to treat.
Gao K; Yuan C; Wu R; Chen J; Wang Z; Fang Y; Calabrese JR
Neurosci Bull; 2015 Oct; 31(5):572-88. PubMed ID: 26024955
[TBL] [Abstract][Full Text] [Related]
19. Clinical highlights in bipolar depression: focus on atypical antipsychotics.
Calabrese JR; Elhaj O; Gajwani P; Gao K
J Clin Psychiatry; 2005; 66 Suppl 5():26-33. PubMed ID: 16038599
[TBL] [Abstract][Full Text] [Related]
20. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]